Cleveland, OH, United States
Cleveland, OH, United States

Time filter

Source Type

The International Association of HealthCare Professionals is pleased to welcome Patrick J. Lynch, Radiologist to their prestigious organization with his upcoming publication in The Leading Physicians of the World. Dr. Patrick J. Lynch is a highly trained and qualified physician with a vast expertise in all facets of his work, especially women’s imaging, mammography, ultrasonography, and breast MRI. He has been in practice for nearly three decades and is currently serving patients within CNY Diagnostic Imaging Associates in Syracuse, New York. Dr. Lynch’s career in medicine began in 1985, when he graduated from the University of Massachusetts Medical School. Upon receiving his Medical Degree, he completed an internship in Internal Medicine at the Bay State Medical Institute in 1986, before undertaking his residency in Diagnostic Radiology at the SUNY Upstate Medical Center. Dr. Lynch is certified by the American Board of Radiology, and maintains a professional membership with the American College of Radiology and the Radiological Society of North America, allowing him to stay current with the latest advances in his field. He attributes his successful career to his continuous hard work and motivation for doing what he loves. When he is not assisting his patients, Dr. Lynch enjoys swimming, traveling, and spending time with his family. Learn more about Dr. Patrick J. Lynch here: http://www.cnydiagnosticimaging.com/ and be sure to read his upcoming publication in The Leading Physicians of World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com


News Article | May 23, 2017
Site: www.eurekalert.org

Washington, D.C. - According to a study presented at the American College of Radiology annual meeting, the use of follow-up imaging is significantly less when initial emergency department (ED) ultrasound examinations are interpreted by a radiologist than a nonradiologist. The work, conducted by researchers at the Harvey L. Neiman Health Policy Institute, was named an ACR 2017 Gold Merit Abstract Award recipient in the Advocacy, Economics and Health Policy category. The researchers used 5 percent Medicare data files from 2009 through 2014 to identify patients in the ED setting where the patient underwent an initial ultrasound examination. They determined whether the initial ultrasound was interpreted by a radiologist or a nonradiologist and then summed all additional imaging events occurring within 7, 14 and 30 days of each initial ED ultrasound. The differences in the mean number of downstream imaging procedures for radiologists and nonradiologists were calculated. "We found that radiologists still interpret that vast majority of ED US. Of 200,357 ED ultrasound events, 81.6 percent were interpreted by radiologists and 36,788 by nonradiologists," said Van Carroll, MD, MPH, a radiology resident at the Brookwood Baptist Health Diagnostic Radiology Residency Program. Carroll and his colleagues discovered that across all study years, ED patients with ultrasounds interpreted by nonradiologists underwent 1.08 more imaging studies within seven days, 1.22 more imaging studies within 14 days, and 1.34 within 30 days of the initial ED ultrasound event. For both radiologists and nonradiologists, the volume of subsequent imaging decreased over time. Despite that decline, differences in follow-up imaging between radiologists and nonradiologists persisted over time. "While the causes of this difference are not clear, the previously documented higher use of limited ultrasound examinations by nonradiologists or a lack of confidence in the interpretations of nonradiologists may potentially explain this increase in follow-up imaging examinations," said Bibb Allen Jr., MD, FACR, a co-author and chair of the Neiman Institute advisory board. Allen added that further analysis will be necessary to fully elucidate the causes of the discrepancy since resource use will be a critical metric in federal health care reform. "Since emerging federal health reform includes cost and resource use as part of the Medicare Quality Payment Program, emerging patterns of care such as point of care ultrasound should include resource use in outcomes evaluation. Efforts toward improving documentation of findings and archiving of images as well as development of more robust quality assurance programs could all be beneficial." ACR 2017 - The Crossroads of Radiology is taking place through May 25 at the Washington Marriott Wardman Park Hotel in Washington, D.C. Visit the ACR 2017 website to view the full abstract. To arrange an interview with a Neiman Institute spokesperson, contact Nicole Racadag at (703) 716-7559 or nracadag@neimanhpi.org. The Harvey L. Neiman Health Policy Institute is one of the nation's leading medical imaging socioeconomic research organizations. The Neiman Institute studies the role and value of radiology and radiologists in evolving health care delivery and payment systems and the impact of medical imaging on the cost, quality, safety and efficiency of health care. Visit us at http://www. and follow us on Twitter, LinkedIn and Facebook.


HOUSTON - Select breast cancer patients who achieved pathologic complete response (pCR) after chemotherapy may be able to avoid follow-up breast and lymph node, or axillary, surgery, according to new findings from researchers at The University of Texas MD Anderson Cancer Center. The study, published today in JAMA Surgery, identifies the exceptional responders who are at lowest risk for local metastases and thereby are candidates for less invasive treatment options. Worldwide, triple negative (TN) and HER-2 positive breast cancers account for about 370,000 women diagnosed annually, explains Henry Kuerer, M.D., Ph.D., professor of Breast Surgical Oncology and the study's principal investigator. In as many as 60 percent of these patients, neoadjuvant chemotherapy (NCT), given as the primary treatment, can result in pCR, or absence of residual disease, in both the breast and axillary lymph nodes. "This high rate of pCR naturally raises the question of whether breast surgery is required for all patients, particularly those who will receive adjuvant radiation," said Kuerer. "An important secondary question in these exceptional responders is whether we can also omit axillary surgery to remove lymph nodes." In order to determine those patients for whom surgery may be avoided, it is necessary to accurately identify those with a pCR following NCT. However, standard breast imaging techniques were not capable of accurately predicting residual disease. Recently Kuerer completed a clinical feasibility trial investigating the utility of image-guided biopsies to predict breast pCR. The preliminary results of that study, originally presented at the 2016 San Antonio Breast Cancer Symposium, revealed the technique to have 100 percent accuracy and 100 percent predictive value for determining residual disease following NCT. "By doing the same image-guided, percutaneous needle biopsies after NCT that we do at time of diagnosis, our preliminary research revealed we can accurately predict which women will have a complete response," said Kuerer. "With that knowledge, there's an obligation to test whether no surgery, or 'ultimate breast conserving therapy,' is safe." The current study sought to determine if patients achieving a pCR following NCT also may avoid axillary surgery for nodal metastases in addition to breast surgery. The prospective single-institution cohort study enrolled 527 women with T1-T2/N0-N1 stage triple negative (264) or HER-2 positive (263) breast cancer treated at MD Anderson between January 2010 and December 2014. All participants received NCT followed by standard breast and nodal surgery. Clinical staging was determined prior to NCT by core biopsy or fine-needle aspiration, followed by clinical examination, mammography and ultrasound of the breast and axilla. Breast pCR was defined as no residual disease at the time of surgery. Axillary pCR was defined as no evidence of metastatic carcinoma. Overall, 36.6 percent of patients achieved a breast pCR, with a slightly higher rate among TN (37.5 percent) than HER-2 positive (35.7 percent) patients. Of patients presenting with N1 disease, 77 (32.5 percent) achieved a breast pCR compared to 116 of those with N0 stage disease (40 percent). All 116 N0 stage patients with a breast pCR also achieved axillary pCR. Similarly, 89.6 percent of patients with N1 disease and a breast pCR were also free of nodal metastases. Overall, there were no significant differences between patients with TN and HER-2 positive breast cancers. "In our study, patients achieving a breast pCR were more than seven times less likely to have residual nodal disease, with even more pronounced differences among patients presenting with N0 stage disease," said Audree Tadros, M.D., fellow in Breast Surgical Oncology and the study's lead author. "Based upon these findings, we anticipate women with initial node-negative disease may avoid breast and axillary surgery if they achieve a pCR after NCT and move on to standard radiotherapy." To investigate the efficacy and safety of this approach, MD Anderson's Institutional Review Board has approved a Phase II clinical trial, which is now open at MD Anderson and will soon open within the MD Anderson Cancer Network®. The study is enrolling women with Stage I and II HER2-positive and TN breast cancer. Study participants who achieve image-guided, biopsy-proved pCR after NCT will undergo whole-breast radiation, without surgery. In those with initial, ultrasound-proven node-negative disease, axillary surgery will also be avoided. The trial will be the first using image-guided biopsies in this setting and not include surgery. "There is an urgency to test whether surgery is needed. In conversations with my patients, many express concerns about overtreatment. They want the most personalized care with as minimal treatment as possible," said Kuerer. "If some women are able to avoid unnecessary surgery, it would be groundbreaking for patients - both physically and psychologically." Additional authors on the all-MD Anderson study include: Dalliah M. Black, M.D., Anthony Lucci Jr., M.D., Abigail S. Caudle, M.D., Sara M. DeSnyder, M.D., Mediget Teshomem, M.D., Makesha Miggins, M.D., Rosa F. Hwang, M.D., and Kelly K. Hunt, M.D., all of Breast Surgical Oncology; Wei T. Yang, M.D, Gaiane M. Rauch, M.D., Ph.D., Beatriz E. Adrada, M.D., and Tanya Moseley, M.D., all of Diagnostic Radiology; Savitri Krishnamurthy, M.D., Pathology; Benjamin D. Smith, M.D., Radiation Oncology; and Vicente Valero, M.D., and Carlos H. Barcenas, M.D., Breast Medical Oncology. The study was financially supported by the PH and Fay Etta Robinson Distinguished Professorship in Cancer Research and a Cancer Center Support Grant from the National Institutes of Health (CA16672).


The International Association of HealthCare Professionals is pleased to welcome Mohammad A. Bilal, MD, Interventional Radiologist, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. Dr. Mohammad A. Bilal is a highly trained and qualified radiologist with an extensive expertise in all facets of his work, especially percutaneous abdominal drainage and venous catheterization. Dr. Bilal has been in practice for more than 13 years and is currently serving as Director of Vascular and Interventional Radiology in Port Jefferson, New York. He is also affiliated with John T. Mather Memorial Hospital and Stony Brook University Hospital. Dr. Mohammad A. Bilal attended Boston University School of Medicine, where he graduated with his Medical Degree. Following his graduation, he subsequently completed his residency in Diagnostic Radiology and then fellowship in Vascular and Interventional Radiology at Long Island Jewish Medical Center. Dr. Bilal is board certified in Diagnostic, Vascular, and Interventional Radiology by the American Board of Radiology. To keep up to date with the latest advances in his field, he maintains professional memberships with the Society of Interventional Radiology, the Radiological Society of North America, the American Roentgen Ray Society, the American College of Radiology, the American Medical Association, the Suffolk County Medical Society, and the Medical Society of the State of New York. He attributes his success to his excellent training, interpersonal skills, patience, commitment, and his excellent support staff. In his free time, Dr. Bilal enjoys traveling, watching movies, and dining out. Learn more about Dr. Bilal by reading his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com


The International Association of HealthCare Professionals is pleased to welcome Robert J. Schmall, MD, Diagnostic Radiologist to their prestigious organization with his upcoming publication in The Leading Physicians of the World. Dr. Robert J. Schmall is a highly trained and qualified physician with an extensive expertise in all facets of his work, especially vascular and interventional radiology. Dr. Schmall has been in practice for 19 years and is currently serving patients within Radiology Consultants of Iowa in Cedar Rapids, Iowa. Dr. Schmall attended the University of Iowa College of Medicine in Iowa City, where he graduated with his Medical Degree in 1991. He subsequently undertook his residency training in Radiology at the Naval Medical Center San Diego. Then he completed his fellowship training in Vascular and Interventional Radiology at the University of Michigan. Dr. Schmall is board certified in Diagnostic Radiology by the American Board of Radiology. He also has his Certificate of Additional Qualification in Vascular and Interventional Radiology. To keep up to date with the latest advances and developments in his field, he maintains professional memberships with the Radiology Society of North America, the American College of Radiology, and the Society of Interventional Radiology. He attributes his success to his hard work, and when he is not assisting his patients, Dr. Schmall likes to relax by reading and spending time with his family. Learn more about Dr. Schmall here: http://www.rciowa.com/ and be sure to read his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com


The International Association of HealthCare Professionals is pleased to welcome Pooja Renjen, MD, Radiologist, to their prestigious organization with her upcoming publication in The Leading Physicians of the World. Dr. Pooja Renjen is a highly trained and qualified radiologist with an extensive expertise in all facets of her work, especially pediatric radiology. Dr. Renjen has been in practice for more than 12 years and is currently serving patients within Pediatric Radiology in New York City, New York. She is also an Assistant Professor of Radiology at Weill Cornell Medical College, and an Assistant Attending Radiologist at New York-Presbyterian Hospital Weill Cornell Campus. Dr. Pooja Renjen earned her Bachelor’s Degree from Johns Hopkins University with a double major in Biology and Economics in 2000, and was elected Phi Beta Kappa upon graduation. She then attended New York University School of Medicine, where she graduated with her Medical Degree in 2004 and was inducted to the Alpha Omega Alpha. Following her graduation, Dr. Renjen completed her Internal Medicine internship at the Hospital of the University of Pennsylvania, where she remained for her Diagnostic Radiology residency, serving as Chief Resident. She then undertook her fellowship training in Pediatric Radiology at the prestigious Children’s Hospital of Philadelphia. Dr. Renjen is double board certified in both Diagnostic Radiology and Pediatric Radiology, and she is renowned as an expert pediatric radiologist. With an interest in international radiology outreach and education, Dr. Renjen spent time in both Botswana and Ethiopia and founded a radiology resident elective, and has participated in teaching a pediatric radiology fellowship. To keep up to date with the latest advances in her field, she maintains a professional membership with the Radiological Society of North America. She attributes her success to her family members, experience, and the opportunity to work with excellent doctors. In her free time, Dr. Renjen enjoys traveling. Learn more about Dr. Renje here: https://weillcornell.org/prenjen and be sure to read her upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com


News Article | February 15, 2017
Site: www.prweb.com

Diagnostic Center for Women has announced that Dr. Michael J. Plaza expands use of cryoablation treatment of fibroadenoma to include early stage breast cancer with the Visica® 2 Treatment System. Developed by Sanarus Technologies, the Visica 2 Treatment System is a cryoablation device that uses extreme cold (cryo) to destroy tissue (ablation). The device destroys the tumor by freezing and damaging the adjacent vasculature that fuels tumor growth. Dr. Michael J. Plaza is board-certified by the American Board of Radiology in Diagnostic Radiology. He completed his residency at University of Miami/Jackson Memorial Hospital and breast imaging fellowship at Memorial Sloan-Kettering Cancer Center. Dr. Plaza has become the first radiologist in Miami to provide cryoablation for early stage breast cancer with the Visica 2 Treatment System. Cryoablation—also referred to as tumor freezing—is a minimally invasive procedure done under ultrasound guidance in the doctor’s office or radiology suite. After injection of local anesthesia, a thin probe is inserted through the skin directly into the tumor. Liquid nitrogen is pumped into the probe to form an “ice ball” around the lesion. Freezing destroys the tumor cells, which are then reabsorbed by the body over time. The procedure can be done in less than an hour with most patients reporting minimal discomfort and a resumption of normal activity right away. Little, if any, visible scarring occurs. Because no breast tissue is removed during the procedure, the natural shape of the breast is maintained. Dr. Plaza began using cryoablation for fibroadenoma in February 2016, and expanded to treating early stage breast cancer in October 2016. “We saw great results in treating benign breast tumors, and with the growing evidence in the medical literature, especially the National Cancer Institute Z1072 Trial we decided to expand our practice to include cryoablation of early stage breast cancer,” said Dr. Plaza. In a 5-year multicenter study funded by the National Cancer Institute and sponsored by the Alliance for Clinical Trials in Oncology, cryoablation with the Visica 2 Treatment System was shown to be 100% effective for complete ablation of invasive ductal breast cancer tumors <1.0 cm. The Visica 2 Treatment System was the exclusive device used in the Z1072 study and showed cryoablation to be effective in 92% of the targeted lesions. Results from this breast cancer study (ACOSOG Z1072), which included a 5-year follow-up, were published in the Annals of Surgical Oncology. “Cryoablation is an evolution in the treatment of early stage breast cancer. Unlike surgery, it is a minimally invasive procedure that preserves the shape of the breast and can be performed in the office under 30 minutes while the patient is awake” Dr. Plaza explains. “Patients can typically return to work the next day. I am excited to bring this modality to the patients in Miami.” Cryoablation with the Visica 2 Treatment System is a nonsurgical option for patients that have been diagnosed with early stage breast cancer, is visible on sonogram and has been confirmed with a biopsy. About Diagnostic Center for Women The Diagnostic Center For Women is a premier imaging facility focused on fostering female wellness. Established in 1999, they are committed to providing the most reliable and comprehensive testing available. Their facility is accredited in mammography, breast and body MRI and obstetric and gynecologic ultrasound by the following organizations: American College of Radiology (ACR), Mammography, Intersocietal Accreditation Commission (IAC), Breast MRI, Body MRI, and American Institute of Ultrasound Medicine (AIUM), Obstetric and Gynecologic Ultrasound. “At the Diagnostic Center for Women, we understand your unique health needs.” Find out more at http://www.dxforwomen.com About Sanarus Technologies In 2001, the Visica® 2 Treatment System was the first available for cryoablation of fibroadenomas. Since then, our system has been used to successfully treat thousands of patients. The Visica 2 Treatment System is FDA-cleared for the ablation of cancerous or malignant tissue and benign tumors. At Sanarus, we develop innovative solutions for the nonsurgical treatment of breast tumors. We are headquartered in Pleasanton, CA, and all of our products are manufactured in the USA. Find out more at http://www.sanarus.com


News Article | February 15, 2017
Site: www.prweb.com

ROSELAND, N.J. — Author Patrick J. Conte, MD, PhD has pondered this question, “Is there a reason why we were born, and do we all have a purpose in life?” In his book, “Mysteries of Life, Death and Beyond” (published by Balboa Press), he attempts to answer it and hopefully guide readers on an amazing and somewhat mystical journey. He takes them from the creation of the known universe and through the time – space continuum of evolution, the effects of karmic interferences, the theory of reincarnation and the development and expressions of one’s emotional psyche. He accompanies them through the progression of the seven major energy centers of the body called chakras, which are in essence guide posts with instructions that help provide physical and spiritual fulfillment in order that they may enjoy all the wonderful experiences in this life and spiritual bliss in the next. “I believe that people are falling away from their religious beliefs and floundering around in seeking God or some higher power. People need to find out for themselves how to find their path in life. They need to be shown a roadmap so that they can find out for themselves how to live their lives and why,” Conte says. An enlightening and insightful read, “Mysteries of Life, Death and Beyond” will give readers a better understanding on where they came from and for what purpose. It will also help them get answers about matters concerning faith and assist people into finding their true spiritual self and what this life is all about. “Mysteries of Life, Death and Beyond” By Patrick J. Conte, MD, PhD Hardcover | 6x9in | 406 pages | ISBN 9781504359610 Softcover | 6x9in | 406 pages | ISBN 9781504359603 E-Book | 406 pages | ISBN 9781504360371 Available at Amazon and Barnes & Noble About the Author After graduating high school, Patrick J. Conte, MD, PhD attended the American Academy of Mortuary Science in New York City. Upon graduation, he was bestowed the Dean’s award. He was accepted into Stritch School of Medicine of Loyola University in Chicago, upon mustering out of active duty and without having to complete his fourth year of pre-med at Seton Hall. He is certified by the American Board of General Radiology, the American Board of Nuclear Medicine and the American Board of Diagnostic Radiology with Special Competence in Nuclear Radiology. He has been in practice for more than 40 years, and currently the Chief of Nuclear Medicine and senior attending radiologist at St. Joseph Regional Medical Center, Paterson. He is also the author of “Converging Paths of Ancient Ayurveda” and “Modern Medicine, A Western Physician’s Perspective.” For more information, interested parties may log on to patrickcontemd.com. Balboa Press, a division of Hay House, Inc. – a leading provider in publishing products that specialize in self-help and the mind, body, and spirit genres. Through an alliance with indie book publishing leader Author Solutions, LLC, authors benefit from the leadership of Hay House Publishing and the speed-to-market advantages of the self-publishing model. For more information, visit balboapress.com. To start publishing your book with Balboa Press, call 877-407-4847 today. For the latest, follow @balboapress on Twitter. ###


The International Association of HealthCare Professionals is pleased to welcome Gale A. Sisney, MD, FACR, Diagnostic Radiologist, to their prestigious organization with her upcoming publication in The Leading Physicians of the World. Dr. Gale A. Sisney is a highly trained and qualified radiologist with an extensive expertise in all facets of her work, especially breast imaging. Dr. Sisney has been in practice for more than 23 years and is currently serving patients within Global Radiology Outreach in Madison, Wisconsin. She is also serving patients within Radiology Mammography International. Dr. Sisney attended the University of Illinois at Chicago, graduating with her Medical Degree in 1988. Following her graduation, she subsequently completed her Diagnostic Radiology residency at Northwestern University Medical School, before undertaking her fellowship training in Breast Imaging and Intervention at the Swedish Medical Center: Radiology Imaging Associates. She has earned the coveted title of Fellow of the American College of Radiology. In addition to her clinical practice, Dr. Sisney is a lecturer for Herzing University, providing education and training for medical imaging and radiation therapy professionals. To keep up to date with the latest advances in her field, Dr. Sisney maintains professional memberships with the American College of Radiology, the Radiological Society of North America, the Association for American Women Radiologists, the Society of Breast Imaging, the American Roentgen Ray Society, and the Wisconsin Radiological Society. With her wealth of experience and knowledge, Dr. Sisney has been published extensively, and has appeared on several media, radio, and television broadcasts. Dr. Sisney attributes her success to her persistence. Learn more about Dr. Sisney by reading her upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com


The International Association of HealthCare Professionals is pleased to welcome Charif Abdul Rahman Sidani, MD, Radiologist, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. He is a highly trained and qualified radiologist with an extensive expertise in all facets of his work especially diagnostic radiology and neuroradiology. Dr. Sidani has been in practice for more than 13 years and is currently serving as Assistant Professor of Clinical Radiology within the University of Miami-Miller School of Medicine in Miami, Florida. He is also affiliated with Jackson Memorial Hospital. Dr. Sidani attended the American University of Beirut in Beirut, Lebanon, graduating with his Medical Degree in 2003. He subsequently completed an internship and Radiology residency within the same educational, before relocating to the United States and undertaking his fellowship training at the University of Miami/Jackson Memorial Medical Center. Dr. Sidani is double board certified in Neuroradiology and in Diagnostic Radiology by the American Board of Radiology. To keep up to date with the latest advances and developments in his field, Dr. Sidani maintains professional memberships with the American College of Radiology, the American Society for Neuroradiology, and the Lebanese Order of Physicians. With his wealth of experience and knowledge, Dr. Sidani is the recipient of numerous awards and recognitions, including the Henry H. Lerner MD Award for Teaching Excellence in 2014. He attributes his success to the support of his family, his excellent mentors, and hard work. When he is not assisting patients, Dr. Sidani enjoys playing soccer and spending time with his family. Learn more about Dr. Sidani here: http://www.med.miami.edu/ and be sure to read his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com

Loading Diagnostic Radiology collaborators
Loading Diagnostic Radiology collaborators